According to Alaunos Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.16. In 2022 the company made an earnings per share (EPS) of -$0.18 an increase over its 2021 EPS that were of -$0.37.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.16 | -11.11% |
2022 | -$0.18 | -51.35% |
2021 | -$0.37 | -5.13% |
2020 | -$0.39 | -43.48% |
2019 | -$0.69 | -177.53% |
2018 | $0.89 | -264.81% |
2017 | -$0.54 | -59.09% |
2016 | -$1.32 | 30.69% |
2015 | -$1.01 | 225.81% |
2014 | -$0.31 | -52.31% |
2013 | -$0.65 | -46.72% |
2012 | -$1.22 | 19.61% |
2011 | -$1.02 | 41.67% |
2010 | -$0.72 | 118.18% |
2009 | -$0.33 | -72.5% |
2008 | -$1.20 | -15.49% |
2007 | -$1.42 | -4.7% |
2006 | -$1.49 | -97.64% |
2005 | -$63.11 | 1.79% |
2004 | -$62.00 | 5301.17% |
2003 | -$1.15 | |
2002 | N/A | -100% |
2001 | -$0.40 |